Gregory R. Friberg, EVP and Chief R&D Officer at BioMarin Pharmaceutical Inc. ($BMRN), sold shares once on the open market in the last year, totaling nearly $382,000. His most recent sale occurred on February 26, 2026. These sales rank 7,045th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. Friberg made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | A | Common Stock | 19150 | $0.00 | 56,728.0000 | 196,893,000 | 50.96% | 0.01% |
| March 17, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | F | Common Stock | 1629 | $56.05 | 55,099.0000 | 196,893,000 | 2.87% | 0.00% |
| March 16, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | A | Stock Option (Right to Buy Common Stock) | 45600 | $0.00 | 45,600.0000 | 196,893,000 | 9999.99% | 0.02% |
| Feb. 26, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | S | Common Stock | 6326 | $60.38 | 37,578.0000 | 196,893,000 | 14.41% | 0.00% |
| Oct. 31, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | A | Common Stock | 398 | $45.54 | 43,904.0000 | 196,893,000 | 0.91% | 0.00% |
| Sept. 30, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | F | Common Stock | 3304 | $54.16 | 43,506.0000 | 196,708,000 | 7.06% | 0.00% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | A | Common Stock | 17750 | $0.00 | 46,810.0000 | 196,708,000 | 61.08% | 0.01% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | A | Stock Option (Right to Buy Common Stock) | 41170 | $0.00 | 41,170.0000 | 196,708,000 | 9999.99% | 0.02% |
| Sept. 30, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | A | Stock Option (Right to Buy Common Stock) | 49850 | $0.00 | 49,850.0000 | 191,595,000 | 9999.99% | 0.03% |
| Sept. 30, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | A | Common Stock | 21190 | $0.00 | 21,190.0000 | 191,595,000 | 9999.99% | 0.01% |
| Sept. 30, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Friberg Gregory R | EVP, Chief R&D Officer | A | Common Stock | 7870 | $0.00 | 29,060.0000 | 191,595,000 | 37.14% | 0.00% |